Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-070152

Chief Medical Officer gave up 4,473 shares (to pay taxes)

  • Chief Medical Officer acquired 8,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-01 Option exercise +8,790 140,747 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-01 Shares withheld for taxes −4,473 $3.96 $17,713 136,274 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-01 Option exercise · Restricted Stock Units −8,790 26,369 D
Loading xslF345X06/tm2616710-2_4seq1.xml…